Matches in Wikidata for { <http://www.wikidata.org/entity/Q64652032> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q64652032 description "assaig clínic" @default.
- Q64652032 description "clinical trial" @default.
- Q64652032 description "clinical trial" @default.
- Q64652032 description "clinical trial" @default.
- Q64652032 description "clinical trial" @default.
- Q64652032 description "ensaio clínico" @default.
- Q64652032 description "ensayo clínico" @default.
- Q64652032 description "ensayu clínicu" @default.
- Q64652032 description "essai clinique" @default.
- Q64652032 description "klinisch onderzoek" @default.
- Q64652032 description "клінічне випробування" @default.
- Q64652032 name "Adding Sitagliptin or Pioglitazone to Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin and Sulfonylurea" @default.
- Q64652032 type Item @default.
- Q64652032 label "Adding Sitagliptin or Pioglitazone to Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin and Sulfonylurea" @default.
- Q64652032 prefLabel "Adding Sitagliptin or Pioglitazone to Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin and Sulfonylurea" @default.
- Q64652032 P1050 Q64652032-009CB724-E62C-406E-BBE4-569EE9D3CF30 @default.
- Q64652032 P1132 Q64652032-45FCD4DD-ADD2-4F5B-9F14-F17B838635FA @default.
- Q64652032 P1476 Q64652032-9B0EA334-6C9F-4170-B73F-1D1504DD3EA9 @default.
- Q64652032 P17 Q64652032-3787F197-E72F-40F2-9AB6-0C4D066C3056 @default.
- Q64652032 P1813 Q64652032-30CAFAE3-80D7-41DC-9E68-946E1714DCAF @default.
- Q64652032 P2899 Q64652032-20E1570A-C2C3-43A1-B0D9-3A7B71425419 @default.
- Q64652032 P3098 Q64652032-D9810DF4-378A-494A-B4B0-FC573FD83082 @default.
- Q64652032 P31 Q64652032-E83FBED9-8200-423B-A278-595E5CA05735 @default.
- Q64652032 P4135 Q64652032-8FE553C4-EC84-4BCA-822A-F771CE5B376D @default.
- Q64652032 P4844 Q64652032-B19E56FD-2F13-48E1-BAF1-CDE09B3A4360 @default.
- Q64652032 P580 Q64652032-C9A64DDB-2560-4DF8-9146-52F5464CD9E1 @default.
- Q64652032 P582 Q64652032-AD5A88B2-EF78-42FA-BACB-5206BEB32354 @default.
- Q64652032 P6099 Q64652032-4CC6C666-C3F8-4990-839F-F185EE83D3B2 @default.
- Q64652032 P6153 Q64652032-B7B0E43F-0EC3-4B3D-ACFB-1D4E6147DFAC @default.
- Q64652032 P8363 Q64652032-F44EE426-31ED-40F9-8AEE-7FD88DE8E84B @default.
- Q64652032 P1050 Q12206 @default.
- Q64652032 P1132 "+120" @default.
- Q64652032 P1476 "Efficacy of Adding Sitagliptin or Pioglitazone to Patients With Type 2 Diabetes Insufficiently Controlled With Metformin and Sulfonylurea" @default.
- Q64652032 P17 Q865 @default.
- Q64652032 P1813 "JAS" @default.
- Q64652032 P2899 "+20" @default.
- Q64652032 P3098 "NCT01195090" @default.
- Q64652032 P31 Q30612 @default.
- Q64652032 P4135 "+80" @default.
- Q64652032 P4844 Q19484 @default.
- Q64652032 P580 "2009-10-01T00:00:00Z" @default.
- Q64652032 P582 "2011-10-01T00:00:00Z" @default.
- Q64652032 P6099 Q42825046 @default.
- Q64652032 P6153 Q6724292 @default.
- Q64652032 P8363 Q78089383 @default.